Cases 41 - 50 of 216
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00227
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma Limited et al
as 1:2022cv00141
Plaintiff:
Sanofi-Aventis U.S. LLC and Sanofi Mature IP
Defendant:
Aurobindo Pharma Limited, AuroMedics Pharma LLC and Eugia Pharma Specialties Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Aurobindo Pharma Limited et al
as 1:2022cv00037
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00017
Plaintiff:
Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and others
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC
Cause Of Action: 35 U.S.C. § 271
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2021cv20723
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 3:2021cv20723
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271
Allergan, Inc. v. Aurobindo Pharma Limited et al
as 1:2021cv01808
Plaintiff:
Allergan, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Limited
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01735
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01707
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
